ThePharmyard Pharmaceutical Pricing, Reimbursement & Distribution in Poland, 2010 and Beyond
Pay-as-you-go medical and pharmaceutical industry information About Us | Contact Us | Terms
The Publishers // JustPharmaReports

Browse the catalogue using the navigation menu to explore further back into the database, or use the search tool to research throughout the store.

Products In JustPharmaReports (Total Products 9, Showing: 1 -> 9)
Access to Hospital Pharmaceutical Markets in the United Kingdom Access to Hospital Pharmaceutical Markets in the United Kingdom
Our Price: £850.00
This Justpharmareports’ publication aims to clarify the situation for the UK, a particularly challenging country with four different public healthcare systems, numerous stakeholders, regular reforms, and rigorous health technology assessment.
CLICK TO BUY ONLINE NOW! | Read full details
Complete Guide to the 2009 PPRS, NICE & other Pharmaceutical Cost Containment Measures in the United Kingdom Complete Guide to the 2009 PPRS, NICE & other Pharmaceutical Cost Containment Measures in the United Kingdom
Our Price: £850.00
This report by Donald Macarthur provides in one place fully-researched, up-to-date information and interpretation on all the market access barriers facing pharmaceutical companies in the four countries that make up the United Kingdom.
CLICK TO BUY ONLINE NOW! | Read full details
Distribution and Patient Support for Speciality Medicines in Europe Distribution and Patient Support for Speciality Medicines in Europe
Our Price: £650.00
This expert report written by Donald Macarthur, Distribution and Patient Support for Speciality Medicines in Europe, provides succinct information and analyses to help companies make the right selection for their particular product.
CLICK TO BUY ONLINE NOW! | Read full details
Orphan Drugs in Asia-Pacific: From designation to pricing, funding & market access Orphan Drugs in Asia-Pacific: From designation to pricing, funding & market access
Our Price: £1450.00
This expert report written by Donald Macarthur, Orphan Drugs in Asia-Pacific: From designation to pricing, funding and market access focuses on five developed markets in the region: Japan, South Korea, Taiwan, Singapore and Australia.
CLICK TO BUY ONLINE NOW! | Read full details
Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access
Our Price: £1450.00
An estimated 1.6 million patients with 38 different rare diseases have potentially benefited from Orphan drugs, and the surge of interest in the area has offered hope to many more. Donald Macarthur explains that the future looks uncertain though.
CLICK TO BUY ONLINE NOW! | Read full details
Pharmaceutical Pricing and Distribution in Japan: The keys to success in the world’s second largest market Pharmaceutical Pricing and Distribution in Japan: The keys to success in the world’s second largest market
Our Price: £1450.00
Donald Macarthur explains why no serious multinational can afford to ignore Japan where it remains a tough and highly competitive market to crack, with the environment for developing and marketing medicines dominated by price.
CLICK TO BUY ONLINE NOW! | Read full details
Pharmaceutical Pricing, Reimbursement & Distribution in Poland, 2010 and Beyond Pharmaceutical Pricing, Reimbursement & Distribution in Poland, 2010 and Beyond
Our Price: £950.00
This expert report written by Donald Macarthur, Pharmaceutical Pricing, Reimbursement & Distribution in Poland, 2010 and Beyond will provide you with clear, comprehensive, fully-researched and up-to-date information
CLICK TO BUY ONLINE NOW! | Read full details
Pharmacy Liberalisation in Europe: Prospects and Implications Pharmacy Liberalisation in Europe: Prospects and Implications
Our Price: £490.00
‘Pharmacy Liberalisation in Europe: Prospects and Implications’ written by Donald Macarthur provides fully-researched, up-to-date information and interpretation on what deregulation could mean to all participants in the medicines’ market.
CLICK TO BUY ONLINE NOW! | Read full details
Prospects for Legalizing Drug (Re-)Importation to the United States Prospects for Legalizing Drug (Re-)Importation to the United States
Our Price: £970.00
Essential reading if you want to protect your business in the US, assess the potential for becoming a player in what could be a new channel or a supplier to it, or are concerned about the knock-on effects in the countries named as potential sources.
CLICK TO BUY ONLINE NOW! | Read full details

Affiliates | About Us | Contact Us | Terms

ThePharmYard is an initiative for the international medical and pharmaceutical industries from NetworkPharma Ltd. Copyright 2010

Other services managed by NetworkPharma: [www.EuropeanCMEforum.eu] [www.KeywordPharma.com] [www.MedCommsForum.com] [www.MedCommsNetworking.co.uk] [www.NetworkPharma.tv] [www.ThePublicationPlan.com]

We accept the following credit and debit cards: amex visa visa_delta visa_electron mastercard switch jcb solo